Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne
Clinical trial NCT07013747 · RECRUITING
Trial details
- NCT number
- NCT07013747
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-03
- Primary completion
- 2029-06-19
- Enrollment
- 228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.